These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 16035128)
1. Antipsychotic use in the elderly: shifting trends and increasing costs. Rapoport M; Mamdani M; Shulman KI; Herrmann N; Rochon PA Int J Geriatr Psychiatry; 2005 Aug; 20(8):749-53. PubMed ID: 16035128 [TBL] [Abstract][Full Text] [Related]
2. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206 [TBL] [Abstract][Full Text] [Related]
3. Mental health-related drug utilization among older adults: prevalence, trends, and costs. Mamdani M; Rapoport M; Shulman KI; Herrmann N; Rochon PA Am J Geriatr Psychiatry; 2005 Oct; 13(10):892-900. PubMed ID: 16223968 [TBL] [Abstract][Full Text] [Related]
4. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. Jano E; Johnson M; Chen H; Aparasu RR Curr Med Res Opin; 2008 Mar; 24(3):709-16. PubMed ID: 18226325 [TBL] [Abstract][Full Text] [Related]
5. Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006. Alessi-Severini S; Biscontri RG; Collins DM; Kozyrskyj A; Sareen J; Enns MW Psychiatr Serv; 2008 May; 59(5):547-53. PubMed ID: 18451015 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotics and mortality in Parkinsonism. Marras C; Gruneir A; Wang X; Fischer H; Gill SS; Herrmann N; Anderson GM; Hyson C; Rochon PA Am J Geriatr Psychiatry; 2012 Feb; 20(2):149-58. PubMed ID: 22273735 [TBL] [Abstract][Full Text] [Related]
7. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol. Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115 [TBL] [Abstract][Full Text] [Related]
8. The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia. Chen L; McCombs JS; Park J Value Health; 2008; 11(1):34-43. PubMed ID: 18237358 [TBL] [Abstract][Full Text] [Related]
9. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease. Edell WS; Rupnow MF Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866 [TBL] [Abstract][Full Text] [Related]
10. How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. Dewa CS; Remington G; Herrmann N; Fearnley J; Goering P Clin Ther; 2002 Sep; 24(9):1466-76. PubMed ID: 12380638 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia. Yury CA; Fisher JE Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959 [TBL] [Abstract][Full Text] [Related]
12. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users. Barnett MJ; Wehring H; Perry PJ J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)]. Förstl H Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111 [No Abstract] [Full Text] [Related]
14. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671 [TBL] [Abstract][Full Text] [Related]
15. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186 [TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions. Wheeler A N Z Med J; 2006 Jul; 119(1237):U2055. PubMed ID: 16862201 [TBL] [Abstract][Full Text] [Related]
17. Use of atypical antipsychotic drugs in patients with dementia. Motsinger CD; Perron GA; Lacy TJ Am Fam Physician; 2003 Jun; 67(11):2335-40. PubMed ID: 12800962 [TBL] [Abstract][Full Text] [Related]
18. Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders. Kopala L; Smith G; Malla A; Williams R; Love L; Talling D; Balshaw R Acta Psychiatr Scand Suppl; 2006; (430):29-39. PubMed ID: 16542323 [TBL] [Abstract][Full Text] [Related]
19. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501 [TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotics for the treatment of dementia-related behaviors: an update. Daiello LA Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]